Kovid-19 Enfeksiyonunun Eşlik Ettiği Erken Evre Çoklu Stent Trombozu Nedenli STEMI Olgu Sunumu

Öz

2019 yılında yeni koronavirüs hastalığı (COVID-19) salgını, özellikle altta yatan kalp hastalığı olan hastalarda insan sağlığı için büyük bir tehdit oluşturmaktadır. Stent trombozu (ST), genellikle büyük miyokard enfarktüsü (MI) veya ölümle ilişkilendirilen nadir bir olaydır. Bu yazıda, koroner stentleme sonrası erken dönemde üçlü antitrombotik tedavi altında çoklu stent trombozlu ST yükselmeli miyokard enfarktüsü (STEMI) gelişen COVID-19 enfeksiyonu olan bir olguyu sunmayı amaçladık.

Anahtar Kelimeler

• Covid-19
• Stent; Thrombosis
• Miyocardial İnfarction

Case Report of STEMI Due to Early Stage Multiple Stent Thrombosis Accompanied By Covid-19 Infection

Abstract

The outbreak of the novel coronavirus disease in 2019 (COVID-19) has a major threat to human health, especially on patients with underlying hearth diseases. Stent thrombosis (ST) is a rare event often associated with large myocardial infarction (MI) or death. Here, we report a case of a patient with COVID-19 infection who developed ST-elevation myocardial infarction (STEMI) with multiple stent thrombosis under triple antithrombotic therapy in the early period after coronary stenting.

Keywords

• Covid-19
• Stent; Thrombosis
• Miyocardial İnfarction

Kaynakça

1. 1. Mauri L, Hsieh WH ve Massaro JM. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007;356(10):1020-9.
2. 2. Cutlip DE,Windecker S ve Mehran R; Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115(17):2344-51.
3. 3. Gori T, Polimeni A ve Indolfi C. Predictors of stent thrombosis and their implications for clinical practice. NatRevCardiol. 2019;16(4):243-256.
4. 4. Hanff TC, Mohareb AM ve Giri J. Thrombosis in COVID-19. Am J Hematol. 2020;95(12):1578-1589. doi: 10.1002/ajh.25982. Epub 2020 Sep 16. PMID: 32857878.
5. 5. De Luca G, Suryapranata H ve Ottervanger JP. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation. 2004;109(10):1223-5.
6. 6. Backhaus SJ, Kowallick JT ve Stiermaier T. Culprit vessel-related myocardial mechanics and prognostic implications following acute myocardial infarction. Clin Res Cardiol. 2020;109(3):339-349.
7. 7. Task Force for the management of COVID-19 of the European Society of Cardiology; Baigent C, Windecker S, Andreini D. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis. Cardiovasc Res. 2022;118(6):1385-1412.
8. 8. Li B, Li W, Li X ve Zhou H. Inflammation: A Novel Therapeutic Target/Direction in Atherosclerosis. Curr Pharm 2017;23(8):1216-1227.

9. 9. Choudhary R, Kaushik A ve Sharma JB. COVID-19 pandemic and stent thrombosis in a post percutaneous coronary intervention patient-a case repor thigh lighting the selection of P2Y12 inhibitor. CardiovascDiagnTher. 2020;10(4):898-901.
10. 10. Zhang Y, Xiao M ve Zhang S. Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19. N Engl J Med. 2020;382(17):e38